Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute megakaryoblastic Leukemia.

I Mirchandani, M Palutke

    Cancer
    |December 15, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Acute megakaryoblastic leukemia is a rare, aggressive cancer. Diagnosis requires specialized tests, as standard methods may not identify the specific leukemia cells, which often leads to rapid disease progression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Blastic mantle cell lymphoma associated with Burkitt-type translocation and hypodiploidy.

    British journal of haematology·2001
    Same author

    CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.

    American journal of clinical pathology·2001
    Same author

    Chromosomal analyses of 52 cases of follicular lymphoma with t(14;18), including blastic/blastoid variant.

    Cancer genetics and cytogenetics·2001
    Same author

    Prostate cancer risk assessment program. A model for the early detection of prostate cancer.

    Oncology (Williston Park, N.Y.)·1999
    Same author

    Reduction of ischemia-reperfusion syndrome after abdominal aortic aneurysmectomy by N-acetylcysteine but not mannitol.

    Acta anaesthesiologica Scandinavica·1996
    Same author

    Double minute chromosomes contain amplified c-myc oncogene sequences in acute myeloid leukemia.

    Hematopathology and molecular hematology·1996
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    Same journal

    Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.

    Cancer·2026
    Same journal

    Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer".

    Cancer·2026
    Same journal

    Pediatric cancer survival in the United States from 2001 to 2021.

    Cancer·2026
    Same journal

    Updates on intratumoral therapies in melanoma.

    Cancer·2026
    Same journal

    Correction to "Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025".

    Cancer·2026
    See all related articles

    Area of Science:

    • Hematology
    • Oncology
    • Cell Biology

    Background:

    • Acute megakaryoblastic leukemia is a rare and aggressive hematologic malignancy.
    • It involves the abnormal proliferation of megakaryoblasts and atypical megakaryocytes in bone marrow and extramedullary sites.
    • Patients often present with thrombocytopenia and minimal blasts in peripheral blood.

    Purpose of the Study:

    • To investigate the morphological, cytochemical, and ultrastructural characteristics of acute megakaryoblastic leukemia.
    • To identify diagnostic challenges and confirm the megakaryocytic origin of leukemia blasts.
    • To report on the clinical outcomes of patients with this rare leukemia.

    Main Methods:

    • Morphological analysis of leukemia blasts.
    • Cytochemical staining (PAS, acid phosphatase).

    Related Experiment Videos

  • Electron microscopy for ultrastructural examination.
  • Demonstration of platelet peroxidase for cell lineage confirmation.

    • Main Results:

    • Leukemia blasts measured 10-20 μm with reticular nuclear chromatin, cytoplasmic projections, and vacuoles.
    • Intense granular PAS positivity and diffuse acid phosphatase reactivity were observed.
    • Standard cytochemical and ultrastructural analyses lacked specific features for megakaryoblast identification.
    • Platelet peroxidase was crucial for confirming megakaryocytic origin.

    Conclusions:

    • Morphological and standard cytochemical features are insufficient for definitive diagnosis of acute megakaryoblastic leukemia.
    • Electron microscopy and specific markers like platelet peroxidase are essential for accurate lineage determination.
    • The studied cases exhibited rapid progression, with all patients dying within 90 days, highlighting the aggressive nature of the disease.